ADC Therapeutics SA (ADCT)
NYSE: ADCT · Real-Time Price · USD
3.770
+0.010 (0.27%)
Apr 28, 2026, 4:00 PM EDT - Market closed

ADC Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2017
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2017
Market Capitalization
4804371921343071,550
Upgrade
Market Cap Growth
332.09%127.27%43.49%-56.31%-80.20%-37.60%
Upgrade
Enterprise Value
6586603732592641,340
Upgrade
Last Close Price
3.773.531.991.663.8420.20
Upgrade
PS Ratio
5.895.382.721.931.4645.71
Upgrade
PB Ratio
--2.35-0.95-0.903.869.34
Upgrade
P/TBV Ratio
----3.8610.12
Upgrade
EV/Sales Ratio
8.088.115.263.731.2639.51
Upgrade
Debt / Equity Ratio
-2.37-2.37-2.19-2.894.151.97
Upgrade
Net Debt / Equity Ratio
-0.96-0.96-0.95-1.010.04-0.84
Upgrade
Net Debt / EBITDA Ratio
-1.69-1.69-1.50-0.91-0.030.53
Upgrade
Net Debt / FCF Ratio
-1.26-1.26-1.54-1.23-0.020.59
Upgrade
Asset Turnover
0.250.250.210.170.380.06
Upgrade
Inventory Turnover
33.4233.4212.389.1816.36-
Upgrade
Quick Ratio
4.144.143.374.494.886.75
Upgrade
Current Ratio
4.374.373.624.975.317.10
Upgrade
Return on Equity (ROE)
-----127.99%-91.72%
Upgrade
Return on Assets (ROA)
-20.56%-20.56%-23.85%-24.54%-13.91%-28.91%
Upgrade
Return on Capital Employed (ROCE)
-41.90%-41.90%-53.50%-57.80%-30.20%-48.10%
Upgrade
Earnings Yield
-29.74%-32.62%-82.03%-179.01%-51.19%-14.84%
Upgrade
FCF Yield
-29.50%-32.34%-64.81%-90.91%-45.28%-15.27%
Upgrade
Buyback Yield / Dilution
-30.78%-30.78%-18.91%-4.55%-1.83%-17.33%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.